References
- Classification of headache. Ad Hoc Committee on Classification of Headache. JAMA 1962; 179(6):717–8
- Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society. Cephalalgia 1988; 8(Suppl 7):1–96
- Diamond S, Dalessio DJ. The practicing physician's approach to headache. New York: Medcom, 1973:2
- Diamond S. Migraine headache. In: Diamond ML, Solomon GD, eds. Diamond and Dalessio's the practicing physician's approach to headache. 6th ed. Philadelphia: WB Saunders, 1999:46–70
- Wolff HG. Headache and other head pain. 2d ed. New York: Oxford University Press, 1963
- Sicuteri F, Testi A, Anselmi B. Biochemical investigations in headache: increase in hydroxyindoleacetic acid excretion during migraine attacks. Int Arch Allergy 1961; 19:55–8
- Curran DA, Hinterberger H, Lance JW. Total plasma serotonin, 5-hydroxyindoleacetic acid and p-hydroxy-m-methoxymandelic acid excretion in normal and migrainous subjects. Brain 1965; 88(5):997–1010
- Olesen J, Larsen B, Lauritzen M. Focal hyperemia followed by spreading oligemia and impaired activation of rCBF in classic migraine. Ann Neurol 1981; 9(4):344–52
- Moskowitz MA. The neurobiology of vascular head pain. Ann Neurol 1984; 16(2): 157–68
- Goadsby PJ, Edvinsson L, Ekman R. Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system. Ann Neurol 1988; 23(2):193–6
- Goadsby PJ, Edvinsson L, Ekman R. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol 1990; 28(2):183–7
- Buzzi MG, Moskowitz MA. The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura mater. Br J Pharmacol 1990; 99(1):202–6
- Critchley M. Definition of migraine. In: Cochrane A, ed. Background to migraine: third migraine symposium. New York: Springer Verlag, 1970:181–2
- Peroutka SJ. Developments in 5-hydroxytryptamine receptor pharmacology in migraine. Neurol Clin 1990; 8(4):829–39
- Maizels M, Scott B, Cohen W, et al. Intranasal lidocaine for treatment of migraine: a randomized, double-blind, controlled trial. JAMA 1996; 276(4):319–21
- Buring JE, Peto R, Hannekens CH. Low-dose aspirin for migraine prophylaxis. JAMA 1990; 264(13):1711–3